Risk factors of different hemoplasma species infections in cats by Michèle Bergmann et al.
RESEARCH ARTICLE Open Access
Risk factors of different hemoplasma
species infections in cats
Michèle Bergmann1*, Theresa Englert1, Bianca Stuetzer1, Jennifer R. Hawley2, Michael R. Lappin2
and Katrin Hartmann1
Abstract
Background: Hemoplasma species (spp.) commonly cause infections in cats worldwide. However, data on risk
factors for infections are limited. The aim of this study was to determine the prevalence of hemoplasma spp.
infections in cats in Southern Germany and to assess risk factors associated with infection.
Results: DNA was extracted from blood samples of 479 cats presented to different veterinary hospitals for various
reasons. DNA of feline hemoplasmas was amplified by use of a previously reported PCR assay. Direct sequencing
was used to confirm all purified amplicons and compared to hemoplasma sequences reported in GenBank. Results
were evaluated in relation to the age, sex, housing conditions, feline leukemia virus (FeLV) and feline immunodeficiency
virus (FIV) status of the cats.
The overall hemoplasma prevalence rate was 9.4% (45/479; 95% CI: 7.08–12.36). ‘Candidatus Mycoplasma (M.)
haemominutum’ (Mhm) DNA was amplified from 42 samples, M. haemofelis from 2, and M. haemocanis from
1 sample. There was a significantly higher risk of hemoplasma infection in cats from multi-cat households, in
outdoor cats, as well as in cats with FIVinfection and in cats with abortive FeLV infection, but not in cats
with progressive or regressive FeLV infection.
Conclusions: Mhm infection is common in cats in Southern Germany. Higher prevalence in multi-cat households and
associations with FeLV infection likely reflect the potential for direct transmission amongst cats. Outdoor access, male
gender, and FIV infection are additional risk factors that might relate to aggressive interactions and exposure to vectors.
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Background
Hemoplasma species (spp.) (or hemotrophic Myco-
plasma spp.) are bacteria without cell walls that can
cause hemolytic anemia in different species. At least 3
hemoplasma spp. have been described in cats, Myco-
plasma (M.) haemofelis (Mhf), ‘Candidatus (Ca.) M.
haemominutum’ (Mhm), and ‘Ca. M. turicensis’ (Mtc).
Hemoplasma spp. attach to the external surface of red
blood cells. Besides transmission through arthropod vec-
tors, there is evidence of horizontal transmission (e.g.,
blood transmission during aggressive interactions be-
tween cats, blood transfusion) between cats [17].
Hemoplasma strains that occur in cats differ in their
size and pathogenicity. Mhf and Mtc seem to have a
higher pathogenicity and are more often associated with
anemia than Mhm [2]. However, clinical relevance of
hemoplasmas as a cause of anemia is not fully under-
stood. Many authors believe them to be an important
primary cause of anemia [20, 21, 25]; others regard
hemoplasmas more as opportunistic pathogens [5, 12].
Natural hemoplasma infection is mostly subclinical.
Clinical signs can occur after a longer latency under im-
munosuppressed conditions. Feline immunodeficiency
virus (FIV) and feline leukemia virus (FeLV) infection
can be associated with the development of clinical signs
in some cats [4, 5, 24]. After developing clinical signs,
alternating periods with anemia and subclinical phases
can occur [2, 25].
Worldwide, cats are commonly infected by hemo-
plasma spp. [11, 12, 14, 21, 26, 27] and prevalence was
found to be 9.9% in Switzerland [27] and 38.5% in Africa
[14]. In Southern Germany, two studies investigated the
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prevalence of hemoplasma spp. infection in 135 cats
[11] and in 296 cats [12] so far. These studies only eval-
uated preselected cats with anemia. Current data in a
non-selected cat population are missing. Thus, the aim
of the present study was to determine the prevalence
of hemoplasma spp. by investigating blood samples of
479 cats by PCR. In addition, associations between
hemoplasma spp. infections with the age, sex, housing




The 479 cats evaluated in this study were presented to
different veterinary clinics in Southern Germany for
various reasons. Health status of the cats was evaluated
by physical examination. In each cat, a complete blood
count (CBC) was performed and the FIV and FeLV
status was examined. FIV antibodies were detected using
a commercial enzyme-linked immunosorbent assay
(ELISA) (SNAP Kombi Plus FeLV/FIV antibody test®,
IDEXX GmbH, Ludwigsburg, Germany). FeLV infection
status was investigated by performing tests for free
FeLV p27 antigen using a commercial ELISA (SNAP
Kombi Plus FeLV/FIV antibody test; IDEXX GmbH,
Ludwigsburg, Germany), FeLV provirus using poly-
merase chain reaction (PCR) as well as anti-FeLV-p45
antibodies using an indirect ELISA, both as previously de-
scribed [1]. Progressively FeLV- infected cats are persist-
ently viremic and thus, FeLV antigen- and provirus-
positive [9]. Regressively FeLV-infected cats are antigen-
negative and provirus-positive; they are considered FeLV
carriers. Cats with abortive FeLV infection never become
viremic; they are antigen-, and provirus-negative but have
FeLV-specific antibodies [9].
A total of 298 cats were male (62.2%) and 181 cats
were female (37.8%) (Table 1). The cats´ ages ranged
from 3 months to 19 years. Median age was 7.4 years
(age of 40 cats was unknown). Of the 468 cats, 106
(22.6%) were purebred cats and 362 (77.4%) were
Domestic Shorthair (DSH). Breed was unknown in 11
(2.3%) cats. Nine of 479 cats (1.9%) were progressively
FeLV-infected, 7 of 479 cats (1.5%) were regressively
FeLV-infected, and 22 of 479 cats (4.5%) were abortively
FeLV-infected. A total of 7 cats were FIV antibody-
positive (1.5%); two of these 7 FIV-infected cats were
also progressively FeLV-infected.
Hemoplasma spp. PCR
Total DNA had previously been extracted from whole
blood of the 479 cats using the MagNA Pure LC Total Nu-
cleic Acid Isolation Kit (Roche Diagnostics AG, Rotkreuz,
Switzerland) and stored at −80 °C until assayed in this
study. The samples were thawed at room temperature and
Table 1 Cats with and without hemoplasma species (spp.) infection, and analysis of the risk factors housing conditions, feline
immunodeficiency virus (FIV), and feline leukemia virus (FeLV) infection status
n Hemoplasma spp.-positivea Hemoplasma spp.-negativea p Mhma Mhfa Mhca
Total 479 45 (9.4) 434 (90.6) - 42 (93.3) 2 (4.5) 1 (2.2)
Age (median) 439 9.0 years 7.2 years - 9.3 17 2
Gender male 298 38 (12.8) 260 (87.2) 0.001 37 (97.4) 0 (0.0) 1 (2.6)
(n = 470) female 181 7 (3.9) 174 (96.1) 5 (71.4) 2 (28.6) 0 (0.0)
Origin shelter 56 10 (17.9) 56 (82.1) 0.104 10 (100.0) 0 (0.0) 0 (0.0)
(n = 479) private 423 35 (8.3) 388 (91.7) 32(91.4) 2 (5.7) 1 (2.9)
Household multi-cat 378 44 (11.6) 334 (88.4) 0.007 41 (93.2) 2 (4.5) 1 (2.3)
(n = 445) single-cat 67 1 (1.5) 66 (98.5) 1 (100.0) 0 (0.0) 0 (0.0)
Access outdoor 229 37 (16.2) 192 (83.8) <0.0001 39 (95.1) 2 (4.9) 0 (0.0)
(n = 432) indoor 203 4 (2.0) 199 (98.0) 3 (75.0) 0 (0.0) 1 (25.0)
FIV infection positive 7 5 (71.4) 2 (28.6) <0.0001 5 (100.0) 0 (0.0) 0 (0.0)
(n = 477) negative 470 40 (8.5) 430 (91.5) 37 (92.5) 2 (5.0) 1 (2.5)
Progressive FeLV infection positive 9 1 (11.1) 8 (88.9) ns 1 (100.0) 0 (0.0) 0 (0.0)
(n = 479) negative 470 44 (9.4) 426 (91.5) ns 41 (93.2) 2 (4.5) 1 (2.3)
Regressive FeLV infection positive 7 2 (28.6) 5 (71.4) ns 2 (100.0) 0 (0.0) 0 (0.0)
(n = 479) negative 472 43 (9.1) 429 (90.9) ns 40 (93.0) 2 (4.7) 1 (2.3)
Abortive FeLV infection positive 22 12 (54.5) 10 (45.5) <0.0001 12 (100.0) 0 (0.0) 0 (0.0)
(n = 459) negative 437 28 (6.4) 409 (93.6) 23 (82.2) 2 (7.2) 1 (3.6)
n numbers of cats in every group, p p-value, ns not significant, Mhm ‘Candidatus Mycoplasma (M.) haemominutum’ , Mhf M. haemofelis, Mhc M. haemocanis; athe
percentages are presented in parenthesis
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prepared for the amplification of hemotropic Mycoplasma
spp. DNA in a previously reported conventional polymerase
chain reaction (PCR) assay [10]. Briefly, each 2.5 μl DNA
sample was added to the PCR master mix (10 mM Tris,
pH 8.3, 50 mM KCl, 3.5 mM MgCl2, 200 μM each dNTP,
400 μM dUTP, 0.5 units uracil N-glycosylase (UNG)
and 1.25 units Taq polymerase) with the final reaction
volume of 25 μl.
PCR products were visualized on a 3% agarose gel
using 6X EZVision One DNA Dye (Amersco; Solon,
OH) according to manufacturer specifications.
Appropriate negative and positive controls were run
with each sample. Positive PCR controls were obtained
from diagnostic whole blood samples received by the
Center for Companion Animal Studies (Department of
Clinical Sciences, Colorado State University). Negative con-
trols consisted of PCR (molecular grade) water being added
in lieu of DNA template. Any positive sample was purified
(QIAquick Gel Extraction Kit; Qiagen Germantown, MD)
and sequenced to confirm genus and species (Colorado
State University Proteomics and Metabolomics Facility;
Fort Collins Colorado).
Statistical analysis
Statistical analysis was performed with Graph PadPrism
6.0. Confidence intervals were determined by an exact bi-
nomial test. The exact binomial test was one-tailed and
was used to prove the alternative hypotheses that the
prevalence of hemoplasma infection was within the 95%
confidence interval (CI). A significance level of < 0.05 was
chosen. Fisher´s exact test was used to assess associations
between hemoplasma infection, cats´ age, gender, and
housing conditions, as well as FIV and FeLV status.
Results
Prevalence of hemoplasma spp. infections
The overall hemoplasma prevalence rate was 9.4% (45/
479; 95% CI: 7.08–12.36) (Table 1). Mhm DNA was
amplified from 42 samples, Mhf from 2 samples, and
Mycoplasma hemocanis (Mhc) from 1 sample (Table 1).
All PCR-negative and extract-negative controls were
always negative in all assays.
Hemoplasma-infected cats
Of the hemoplasma-positive cats, 84.5% (38/45) were
male. Infected cats ages ranged from 9 months to 17 years
(median 9 years). Most of the hemoplasma-infected cats
were ≥ 9 years old (25/41); 8 cats were ≤ 3 years old (age of
4 cats was unknown).
Most of the infected cats were allowed to roam outside
(90.2%; 37/41) and lived in multi-cat-households (97.8%;
44/45) (Table 1).
Ten of the infected cats were healthy and presented
for neutering and/or routine health checks (22.2%; 10/
45); the remaining cats were presented with a history of
illness (77.8%; 35/45). Six infected cats had anemia
(13.4%; 6/45), whereas 67 (21.1%; 67/317) of the non-
infected cats had anemia. The hematocrit of the 6
hemoplasma-infected anemic cats ranged from 0.22 to
0.29 l/l (reference range: 0.30–0.44 l/l). None of these
cats showed signs of regenerative anemia, such as poly-
chromasia, macrocytosis, and in none of these cats nu-
cleated red blood cells were present.
Risk factors
Due to the low number of cats infected with the species
Mhf or Mhc, all of the hemoplasma-infected cats were
evaluated together for risk factor analysis. Male cats had
a significantly higher risk of infection with a hemo-
plasma spp. than female cats (p = 0.001; odds-ratio (OR):
3.633; 95% CI: 1.586–8.322) (Table 1). In addition, cats
with outdoor access (p < 0.0001; OR: 9.59; 95% CI: 3.35–
27.42) and cats from multi-cat households (p = 0.007;
OR: 8.66; 95% CI: 1.18–64.25) had a significantly
higher risk of infection with a hemoplasma spp. Cats
from shelters (p = 0.104; OR: 1.98; 95% CI: 92.8–
421.9) had no significantly higher risk of
hemoplasma-infection than cats from private homes.
Of the hemoplasma-positive cats, 5 cats were coin-
fected with FIV; 12 cats were abortively FeLV-coinfected,
2 cats were regressively and 1 cat was progressively coin-
fected with FeLV. Hemoplasma spp. bacteremia was sig-
nificantly more often found in FIV-positive cats (p <
0.0001; OR: 26.88; 95% CI: 5.05–143.00) and in cats with
abortive FeLV infection (p = 0.019; OR: 2.64; 95% CI:
1.26–5.51). Cats with progressive (p = 0.592) and regres-
sive (p = 0.134) FeLV infections had no higher risk of
being infected with hemoplasma spp..
Mhc-infected cat
The Mhc-infected cat was a 10 months old, female neu-
tered British Shorthair. The cat lived in a multi-cat
household. The cat had no access to outdoors, no con-
tact to dogs, and no travelling history. The cat was pre-
sented for routine health care. Physical and laboratory
examination were unremarkable.
Discussion
The present study revealed an overall prevalence rate of
hemoplasma infections in cats of 9.4%. Worldwide,
prevalence differs between about 10% in Switzerland
[27] to over 30% in Africa [14]. Thus, prevalence of
hemoplasma infection seems to be higher in countries
with warmer climates. The infection rate in Southern
Germany is similar to that in Switzerland, presumably
due to the similar climate. An association between
prevalence of potential vectors and prevalence of feline
hemoplasma infections is likely [18, 23].
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Similar to previous studies, Mhm was the most com-
mon hemoplasma spp. in the present study. None of the
cats was positive for Mtc, although Mtc infections in
cats from Southern Germany have been reported previ-
ously [11, 12]. Surprisingly, a 10 months old British
Short Hair cat was infected with Mhc, the most preva-
lent hemoplasma spp. in dogs. Hemoplasmas are not
necessarily strictly species-specific and there are reports
stating that Mhc could infect cats and that cats might
act as reservoir for Mhc [15, 16]. Mhc is most prevalent
in dogs from Mediterranean countries; transmission is
suspected via Rhipicephalus sanguineus, a tick that is
not endemic in Germany [22, 28]. Source of Mhc infec-
tion in this cat of the present study is unclear. The cat
was never allowed to go out and lived only indoors with-
out any contact to dogs. Tick transmission therefore
seemed unlikely; as this cat was still young, vertical
transmission, which has been reported in cattle, might
be the most likely source of infection [3].
Most of the Mhm- and Mhf-infected cats were older (
≥9 years). Due to the subclinical nature of Mhm
infection, this follows the presumption of becoming
infected as a result of prolonged exposure during life-
time [23, 27].
As reported previously, infection was more prevalent in
male cats and in cats with outdoor access [27]. This sup-
ports the hypotheses of horizontal transmission during ag-
gressive interactions between cats and transmission through
arthropod vectors [17]. In addition, cats from multicat-
households were significantly more likely to be infected with
hemoplasma spp., which could be due to a higher risk for
aggressive interactions in multicat-environments.
Associations between hemoplasma spp. infection and
clinical disease in naturally infected cats are not fully
understood. Natural hemoplasma spp. infection is
mainly subclinical in cats, but some cats develop severe
anemia with fever, inappetence and lethargy [21]. It has
been discussed whether retrovirus and hemoplasma in-
fections are associated and whether immunosuppression
could lead to enhanced pathogenicity of hemoplasma
spp. [8, 23, 27].
A surprisingly strong association of FIV and hemo-
plasma spp. infection was found in the present study.
Cats with hemoplasma infection were 26 times more
likely to be FIV infected. This emphasizes, that hemo-
plasma spp. can be transmitted through similar routes as
FIV, such as through biting. Similar to a recent study,
FIV infection was predominantly associated with Mhm
but not with Mhf and Mtc [23]. However, none of the
hemoplasma FIV-coinfected cats showed signs of clinical
manifestation of hemoplasmosis. It has been discussed
that specific FIV strains might be the reason for more
severe disease in coinfected cats [5], but this has never
been proven so far.
In the present study, cats with hemoplasma infection
were also more likely to be FeLV-infected. This is presum-
ably attributable to outdoor access and multi-cat house-
hold, which increases the risk of FeLV infection through
cat contact [7]. Only 3 of 28 FeLV hemoplasma-coinfected
cats showed mild non-regenerative anemia which was
likely caused by chronic kidney disease present in these 3
cats. In contrast, Harrus and colleagues found that Mhf-
positive and cats positive for FeLV-p27 antigen were more
often anemic than cats with Mhf infection alone [8]. How-
ever, most of the hemoplasma-positive cats in the present
study were only abortively FeLV-infected (12/45), and cats
with abortive FeLV infection never become viremic [9].
Abortive infections develop in immunocompetent cats.
Due to effective immune response, these cats are able to
terminate viral replication, and cats have no clinical signs
[9]. Thus, immunocompetence is likely the reason for the
missing enhanced pathogeniticity of hemoplasmas in the
cats with abortive FeLV coinfections. In addition, all of the
FeLV hemoplasma-coinfected cats were infected with
Mhm, a strain that has an inherently low pathogenicity
[2]. None of the progressively and regressively FeLV
hemoplasma-coinfected cats showed clinical signs either.
All this supports the hypothesis that the association of
FIV and FeLV with hemoplasma spp. infection is likely the
same mode of transmission and not necessarily an en-
hanced pathogenicity.
If hemoplasma spp. infection is clinically apparent, it usu-
ally results in regenerative hemolytic anemia [19]. In the
present study, only 6 Mhm-infected of all 45 hemoplasma-
infected cats had anemia. All of these cats had non-
regenerative anemia, and other diseases that were likely
responsible for the non-regenerative anemia (chronic kid-
ney disease (n = 3), anemia of chronic disease caused by
chronic respiratory tract disease (n = 2); tumor of the cen-
tral nervous system (n = 1); chronic weight loss (n = 1)).
Thus, other reasons than Mhm infection were presumably
responsible for anemia in these cats. Although Mhf is
thought to be more pathogenic, none of the Mhf-infected
cats in the present study showed clinical signs. This could
be due to a low hemoplasma load or infection with a less
virulent strain. The Mhc-infected cat also showed no clin-
ical signs of hemoplasmosis. Pathogenicity of this species in
cats is unknown. Mhc can cause acute disease in immuno-
suppressed [6] or splenectomized dogs [13].
The major limitation of the study was the low number
of cats with Mhf and Mhc infections and the fact that
no cat in the present study was positive for Mtc. Thus,
comparison between the different hemoplasma species
was not possible. In addition, pretreatment of the cats in
the present study was unknown, and treatment with an-
tibiotics, e.g., doxycycline or enrofloxacin, prior to blood
sampling could have led to termination of bacteremia
and underestimation of hemoplasma prevalence [21].
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Conclusions
Feline hemoplasma infection is relatively common in cats,
and if cats are infected, they are usually infected with
Mhm, a species with low pathogenicity. A higher risk ex-
ists for male sex, outdoor access, multi-cat environment,
and FIV- and FeLV-infected cats which seems to be re-
lated to similar mechanisms for transmission during ag-
gressive interactions and through arthropod vectors.
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